BioDiscovery

Curated by Signal

Software solutions for analyzing microarray and next-gen sequencing technologies

Overview

Biodiscovery provides software solutions for analyzing microarray and next-gen sequencing technologies. Its flagship product is the NxClinical, provides genomic analysis of sequencing data and complete variant analysis for heatlhcare providers. In addition, the company provides tools for bioinformatics researchers, such as Nexus Copy Number, Nexus Expression, TCGA Premier, NexusDB and ImaGene.

Key facts

Founded: 1997
Headquarters: El Segundo, United States
Stage: Sign up to view
Industry: High Technology

Contact

Primary office: Sign up to view
Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More High Technology companies

Geophysical Insights
Provider of an AI workbench for seismic interpretation
High TechnologyHouston, United States
EZKL
Platform to authenticate AI and ML models
High TechnologyNew York City, United States
MedTech Wearables
Developer of wearable fitness tracking devices
High TechnologyLa Salle, United States

About BioDiscovery

What does BioDiscovery do?

Biodiscovery provides software solutions for analyzing microarray and next-gen sequencing technologies.

Where is BioDiscovery headquartered?

BioDiscovery is headquartered in El Segundo, United States.

When was BioDiscovery founded?

BioDiscovery was founded in 1997.

Which sector is BioDiscovery in?

BioDiscovery operates in High Technology.

Who are BioDiscovery's competitors?

Companies similar to BioDiscovery include Geophysical Insights, EZKL, and MedTech Wearables.